Back to User profile » Professor Tobias Welte

Papers published by Professor Tobias Welte:


Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET

Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3189-3199

Published Date: 24 November 2021

Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months

Kayser MZ, Drick N, Milger K, Fuge J, Kneidinger N, Korn S, Buhl R, Behr J, Welte T, Suhling H

Journal of Asthma and Allergy 2021, 14:863-871

Published Date: 12 July 2021

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences

Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:987-998

Published Date: 14 April 2021

Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients

Janciauskiene S, Royer PJ, Fuge J, Wrenger S, Chorostowska-Wynimko J, Falk C, Welte T, Reynaud-Gaubert M, Roux A, Tissot A, Magnan A

Journal of Inflammation Research 2020, 13:1021-1028

Published Date: 30 November 2020

Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H

Journal of Asthma and Allergy 2020, 13:605-614

Published Date: 11 November 2020

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort

Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798

Published Date: 5 November 2020

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ

Journal of Asthma and Allergy 2020, 13:115-126

Published Date: 17 February 2020

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort

Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K

Patient Preference and Adherence 2019, 13:1711-1721

Published Date: 10 October 2019

Therapy preferences of patients with lung and colon cancer: a discrete choice experiment

Schmidt K, Damm K, Vogel A, Golpon H, Manns MP, Welte T, Graf von der Schulenburg JM

Patient Preference and Adherence 2017, 11:1647-1656

Published Date: 26 September 2017

Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function

Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:981-987

Published Date: 22 March 2017

Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?

Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:829-837

Published Date: 8 March 2017